PDF herunterladen
CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2021; 30(02): 098-104
DOI: 10.1055/s-0040-1722238
Original Article | Artículo Original

Infección Urinaria en Gestantes: Prevalencia y Factores Asociados en el Eje Cafetero, Colombia, 2018-2019

Urinary Infection in Pregnant Women: Prevalence and Associated Factors in the Eje Cafetero, Colombia, 2018-2019
Franklin José Espitia De La Hoz 
1   Ginecología y Obstetricia, Universidad Militar nueva Granada, Bogota, Columbia
2   Sexología Clínica, Universidad de Alcalá de Henares, Madrid, Spain
3   Uroginecología / FUCS, Hospital de San José / Unicamp, Brasil
› Institutsangaben Financiación Estudio financiado con recursos propios del autor, mediante fondos obtenidos de sus turnos en obstetricia.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Resumen

Objetivo estimar la prevalencia y etiología de las infecciones urinarias en gestantes del Eje Cafetero, así como describir los factores asociados e identificar la sensibilidad a los antibióticos.

Métodos estudio de corte transversal, en gestantes que consultaron, por primera vez, a consulta prenatal, y que tuvieron un resultado positivo en el urocultivo, en tres centros de atención en el Eje Cafetero, entre 2018 y 2019. Se reclutaron 1131 mujeres. Se evaluaron los factores de riesgo asociados, el aislamiento e identificación de los gérmenes involucrados, así como la prevalencia de enterobacterias productoras de β-lactamasas de espectro extendido (BLEE).

Resultados La edad de las mujeres osciló entre 18 y 42 años, promedio de 29,46 ± 5,82 años. La prevalencia global de infección urinaria fue de un 14,94% (IC95%: 11,78-21,46). La etiología más frecuente caracterizó la Escherichia Coli (80,47%), seguida por Klebsiella spp. (9,46%) y Proteus mirabilis (5,91%). La prevalencia de gérmenes BLEE (+) alcanzó el 11,24% (IC95%: 9,47-11,75). Las mujeres con depilación íntima tuvieron mayor riesgo de presentar infección urinaria (OR = 4,62; IC95%: 1,08-8,64) seguida por el tabaquismo (OR = 4,56; IC95%: 2,58-9,81) y la diabetes mellitus (OR = 3,96; IC95%: 1,05-6,54). El uso de protectores íntimos fue mayor en las mujeres con infección urinaria (OR = 2,88; IC95%: 1,02-3,99).

Conclusiones se identificó la infección urinaria en el 14,94% de las gestantes. Se detectó la Escherichia Coli como la etiología más frecuente. La depilación íntima fue el principal factor de riesgo.

Abstract

Objective to estimate the prevalence and etiology of urinary tract infections in pregnant women of the Coffee Region, as well as to describe the associated factors and identify the sensitivity to antibiotics.

Methods cross-sectional study, in pregnant women who consulted for the first time at prenatal consultation, and who had a positive result in urine culture. In three care centers in the Coffee Axis, between 2018 and 2019. 1131 women were recruited. The associated risk factors, the isolation and identification of the germs involved, as well as the prevalence of extended spectrum β-lactamase-producing enterobacteriaceae (BLEE) were evaluated.

Results The age of the women ranged between 18 and 42 years, average of 29.46 ± 5.82 years. The overall prevalence of urinary infection was 14.94% (95% CI: 11.78-21.46). The most frequent etiology characterized Escherichia Coli (80.47%), followed by Klebsiella spp. (9.46%) and Proteus mirabilis (5.91%). The prevalence of ESBL (+) germs reached 11.24% (95% CI: 9.47-11.75). Women with intimate hair removal had a higher risk of developing urinary infection (OR = 4.62; 95% CI: 1.08-8.64) followed by smoking (OR = 4.56; 95% CI: 2.58-9, 81) and diabetes mellitus (OR = 3.96; 95% CI: 1.05-6.54). The use of intimate protectors was greater in women with urinary infection (OR = 2.88, 95% CI: 1.02-3.99).

Conclusions urinary infection was identified in 14.94% of pregnant women. Escherichia Coli was detected as the most frequent etiology. Intimate hair removal was the main risk factor.

Palabras clave

factores de riesgo - infecciones urinarias - mujeres embarazadas - prevalencia

Keywords

risk factors - urinary tract infections - pregnant women - prevalence

Responsabilidades Éticas

Protección de personas y animales. Los autores declaran que los procedimientos seguidos se conformaron a las normas éticas del comité de experimentación humana responsable y de acuerdo con la Asociación Médica Mundial y la Declaración de Helsinki.


Confidencialidad de los datos. Los autores declaran que han seguido los protocolos de su centro de trabajo sobre la publicación de datos de pacientes.


Derecho a la privacidad y consentimiento informado. Los autores han obtenido el consentimiento informado de los pacientes y/o sujetos referidos en el artículo. Este documento obra en poder del autor de correspondencia.




Publikationsverlauf

Eingereicht: 24. August 2020

Angenommen: 17. November 2020

Artikel online veröffentlicht:
04. Februar 2021

© 2021. Sociedad Colombiana de Urología. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • Referencias

  • 1 Cunningham FG, Lucas MJ. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol 1994; 8 (02) 353-373
    CrossrefPubMedGoogle Scholar
  • 2 Gilbert NM, O'Brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Glob Adv Health Med 2013; 2 (05) 59-69 DOI: 10.7453/gahmj.2013.061.
    CrossrefPubMedGoogle Scholar
  • 3 Connolly A, Thorp Jr JM. Urinary tract infections in pregnancy. Urol Clin North Am 1999; 26 (04) 779-787 DOI: 10.1016/s0094-0143(05)70218-4.
    CrossrefPubMedGoogle Scholar
  • 4 Patterson TF, Andriole VT. Bacteriuria in pregnancy. Infect Dis Clin North Am 1987; 1 (04) 807-822
    CrossrefPubMedGoogle Scholar
  • 5 Mikhail MS, Anyaegbunam A. Lower urinary tract dysfunction in pregnancy: a review. Obstet Gynecol Surv 1995; 50 (09) 675-683 DOI: 10.1097/00006254-199509000-00022.
    CrossrefPubMedGoogle Scholar
  • 6 Foley ME, Farquharson R, Stronge JM. Is screening for bacteriuria in pregnancy worthwhile?. Br Med J (Clin Res Ed) 1987; 295 (6592): 270 DOI: 10.1136/bmj.295.6592.270.
    CrossrefPubMedGoogle Scholar
  • 7 Harris RE, Gilstrap III LC. Cystitis during pregnancy: a distinct clinical entity. Obstet Gynecol 1981; 57 (05) 578-580
    PubMedGoogle Scholar
  • 8 Ronald A. Sex and urinary tract infections. N Engl J Med 1996; 335 (07) 511-512 DOI: 10.1056/NEJM199608153350711.
    CrossrefPubMedGoogle Scholar
  • 9 Giraldo PC, Araújo ED, Junior JE, do Amaral RL, Passos MRL, Gonçalves AK. The prevalence of urogenital infections in pregnant women experiencing preterm and full-term labor. Infect Dis Obstet Gynecol 2012; 2012: 878241 DOI: 10.1155/2012/878241.
    CrossrefPubMedGoogle Scholar
  • 10 Raza S, Pandey S, Bhatt CP. Microbiological analysis of isolates in Kathmandu Medical College Teaching Hospital, Kathmandu, Nepal. Kathmandu Univ Med J (KUMJ) 2011; 9 (36) 295-297 DOI: 10.3126/kumj.v9i4.6348. (KUMJ)
    CrossrefPubMedGoogle Scholar
  • 11 Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 2012; 36 (03) 616-648 DOI: 10.1111/j.1574-6976.2012.00339.x.
    CrossrefPubMedGoogle Scholar
  • 12 FitzGerald MP, Graziano S. Anatomic and functional changes of the lower urinary tract during pregnancy. Urol Clin North Am 2007; 34 (01) 7-12 DOI: 10.1016/j.ucl.2006.10.007.
    CrossrefPubMedGoogle Scholar
  • 13 Gilstrap III LC, Cunningham FG, Whalley PJ. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 1981; 57 (04) 409-413
    PubMedGoogle Scholar
  • 14 Esparza GF, Motoa G, Robledo C, Villegas MV. Aspectos microbiológicos en el diagnóstico de infecciones del tracto urinario. Infectio. 2015; 19 (04) 150-160 DOI: 10.1016/j.infect.2015.03.005.
    CrossrefPubMedGoogle Scholar
  • 15 Sheffield JS, Cunningham FG. Urinary tract infection in women. Obstet Gynecol 2005; 106 (5 Pt 1): 1085-1092 DOI: 10.1097/01.AOG.0000185257.52328.a2.
    CrossrefPubMedGoogle Scholar
  • 16 National Institute for Clinical Excellence. 2010 Antenatal care. Report No.: NICE clinical guideline 62
    PubMedGoogle Scholar
  • 17 Perry JD, Butterworth LA, Nicholson A, Appleby MR, Orr KE. Evaluation of a new chromogenic medium, Uriselect 4, for the isolation and identification of urinary tract pathogens. J Clin Pathol 2003; 56 (07) 528-531 DOI: 10.1136/jcp.56.7.528.
    CrossrefPubMedGoogle Scholar
  • 18 Woods G, Washington J. Antibacterial Susceptibility Tests: Dilution and Disk Diffusion Methods. In: Manual of Clinical Microbiology. Sixth edition. Eds: Murray P, Baron E, Pfaller M. et al. American Society of Microbiology; Washington D.C.: 1995
    Google Scholar
  • 19 Asociación Médica Mundial. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. Fortaleza: 64.a Asamblea General de la AMM; 2013
    PubMedGoogle Scholar
  • 20 Colombia. Ministerio de Salud. Resolución 8430 de 1993 (octubre 4): Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Bogotá D.C.: octubre 4 de 1993
    PubMedGoogle Scholar
  • 21 Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 (Suppl 1A): 5S-13S DOI: 10.1016/s0002-9343(02)01054-9.
    CrossrefPubMedGoogle Scholar
  • 22 Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?. J Matern Fetal Neonatal Med 2009; 22 (02) 124-128 DOI: 10.1080/14767050802488246.
    CrossrefPubMedGoogle Scholar
  • 23 Bolton M, Horvath Jr DJ, Li B. et al. Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis. PLoS One 2012; 7 (03) e33897 DOI: 10.1371/journal.pone.0033897.
    CrossrefPubMedGoogle Scholar
  • 24 Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014; 210 (03) 219.e1-219.e6 DOI: 10.1016/j.ajog.2013.10.006.
    CrossrefPubMedGoogle Scholar
  • 25 Mittal P, Wing DA. Urinary tract infections in pregnancy. Clin Perinatol 2005; 32 (03) 749-764 DOI: 10.1016/j.clp.2005.05.006.
    CrossrefPubMedGoogle Scholar
  • 26 Obiogbolu CH, Okonko IO, Anyamere CO. et al. Incidence of Urinary Tract Infections (UTIs) among pregnant women in Akwa metropolis, Southeastern Nigeria. Sci Res Essays 2009; 4 (08) 820-824
    PubMedGoogle Scholar
  • 27 Hamdan HZ, Ziad AH, Ali SK, Adam I. Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital. Ann Clin Microbiol Antimicrob 2011; 10: 2 DOI: 10.1186/1476-0711-10-2.
    CrossrefPubMedGoogle Scholar
  • 28 Masinde A, Gumodoka B, Kilonzo A, Mshana SE. Prevalence of urinary tract infection among pregnant women at Bugando Medical Centre, Mwanza, Tanzania. Tanzan J Health Res 2009; 11 (03) 154-159 DOI: 10.4314/thrb.v11i3.47704.
    CrossrefPubMedGoogle Scholar
  • 29 Sheikh MA, Khan MS, Khatoon A, Arain GM. Incidence of urinary tract infection during pregnancy. East Mediterr Health J 2000; 6 (2-3): 265-271
    CrossrefPubMedGoogle Scholar
  • 30 Al-Haddad AM. Urinary tract infection among pregnant women in Al-Mukalla district, Yemen. East Mediterr Health J 2005; 11 (03) 505-510
    CrossrefPubMedGoogle Scholar
  • 31 Thakur A, Baral R, Basnet P. et al. Asymptomatic bacteriuria in pregnant women. JNMA J Nepal Med Assoc 2013; 52 (192) 567-570 DOI: 10.31729/jnma.2193.
    CrossrefPubMedGoogle Scholar
  • 32 Ahmed S, Shakooh S, Salati SA, Muniem A. Prevalence of asymptomatic bacteriuria among pregnant women in Kashmir. Sri Lanka Journal of Obstetrics and Gynaecology 2011; 33 (04) 158-162 DOI: 10.4038/sljog.v33i4.4804.
    CrossrefPubMedGoogle Scholar
  • 33 Sandhya SK, Mispah P, Kelamane S. Study of asymptomatic bacteriuria in pregnant women: prevalence, isolates and their antibiotic sensitivity pattern. Int J Res Med Sci. 2019; 7 (04) 962-966 DOI: 10.18203/2320-6012.ijrms20191295.
    CrossrefPubMedGoogle Scholar
  • 34 Sanín-Ramírez D, Calle-Meneses C, Jaramillo-Mesa C, Nieto-Restrepo JA, Marín-Pineda DM, Campo-Campo MN. Prevalencia etiológica de infección del tracto urinario en gestantes sintomáticas, en un hospital de alta complejidad de Medellín, Colombia, 2013-2015. Rev Colomb Obstet Ginecol 2019; 70 (04) 243-252 DOI: 10.18597/rcog.3332.
    CrossrefPubMedGoogle Scholar
  • 35 Sharma P, Thapa L. Acute pyelonephritis in pregnancy: a retrospective study. Aust N Z J Obstet Gynaecol 2007; 47 (04) 313-315 DOI: 10.1111/j.1479-828X.2007.00752.x.
    CrossrefPubMedGoogle Scholar
  • 36 Dawkins JC, Fletcher HM, Rattray CA, Reid M, Gordon-Strachan G. Acute pyelonephritis in pregnancy: a retrospective descriptive hospital based-study. ISRN Obstet Gynecol 2012; 2012: 519321 DOI: 10.5402/2012/519321.
    CrossrefPubMedGoogle Scholar
  • 37 Schenkel DF, Dallé J, Antonello VS. Prevalência de uropatógenos e sensibilidade antimicrobiana em uroculturas de gestantes do Sul do Brasil. Rev Bras Ginecol Obstet 2014; 36 (03) 102-106
    CrossrefPubMedGoogle Scholar
  • 38 Casas PR, Ortiz M, Erazo-Bucheli D. Prevalencia de la resistencia a la ampicilina en gestantes con infección urinaria en el hospital universitario San José de Popayán (Colombia), 2007-2008. Rev Colomb Obstet Ginecol 2009; 60 (04) 334-338
    CrossrefPubMedGoogle Scholar
  • 39 Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010; 78 (02) 568-585 DOI: 10.1128/IAI.01000-09.
    CrossrefPubMedGoogle Scholar
  • 40 Blanco VM, Maya JJ, Correa A. et al. Prevalencia y factores de riesgo para infecciones del tracto urinario de inicio en la comunidad causadas por Escherichia coli productor de betalactamasas de espectro extendido en Colombia. Enferm Infecc Microbiol Clin 2016; 34 (09) 559-565 DOI: 10.1016/j.eimc.2015.11.017.
    CrossrefPubMedGoogle Scholar
  • 41 Tejada-Llacsa PJ, Huarcaya JM, Melgarejo GC. et al. Caracterización de infecciones por bacterias productoras de BLEE en un hospital de referencia nacional. An Fac Med 2015; 76 (02) 161-166
    CrossrefPubMedGoogle Scholar
  • 42 Geerlings SE. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 2008; 31 (Suppl. 01) S54-S57 DOI: 10.1016/j.ijantimicag.2007.07.042.
    CrossrefPubMedGoogle Scholar
  • 43 Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B. Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clin Infect Dis 2009; 49 (04) 491-497 DOI: 10.1086/600883.
    CrossrefPubMedGoogle Scholar
  • 44 Salazar E, Salazar E. Aspectos de las infecciones urinarias. Rev. Facultad de Medicina de la UCV 1995; 18: 180-183
    PubMedGoogle Scholar
  • 45 Torrejano M, Calderón L, Quimbayo A. Factors associated with urinary tract infection in pregnant women Pitalito, 2012. Revista Facultad Se Salud 2013; 5 (02) 18-26
    PubMedGoogle Scholar